摘要
目的检测肝细胞癌中凋亡抑制因子survivin的表达,研究其与肝癌临床病理特征的关系;同时研究survivin与原癌基因c-myc表达的相关性。方法采用免疫组织化学技术和Western Blotting技术,检测59例肝癌组织及癌旁非癌组织中survivin和c-myc蛋白的表达。结果59例肝癌组织中36例表达survivin蛋白,其中29例c-myc表达阳性,7例c-myc表达呈阴性或弱阳性;23例不表达survivin蛋白或弱阳性表达者,c-myc的表达5例阳性,18例阴性或弱阳性,而在癌旁非癌组织中未检测到survivin蛋白的表达。survivin的表达与HCC镜下门静脉癌栓及局部肿瘤复发密切相关(P<0.05),而与肿瘤大小,肿瘤包膜,肝硬化及病理分期无关(P>0.05)。HCC中survivin和c-myc表达呈明显正相关(P<0.05)。结论survivin在肝细胞癌中通过加强c-myc的功能促进肝癌的发生发展,survivin有望成为HCC诊断和治疗的新靶点。
Objective To investigate the expression of survivin and its relationship with the clinicopathologic feature of hepatocellular carcinoma (HCC), and the correlation between the expression of survivin and c-myc. Methods In 59 specimens of HCC tissues and non-cancerous adjacent liver tissues, the expression of survivin and c-myc was detected by using immunhischemistry and Western-blotting. Results Of the 36 (61.0%) cases of HCC expression survivin in 59 cases of HCC, 29 were positive for the expression of c-myc and 7 were slightly positive or negative; of the 23 cases without expressing survivin or slightly positive, 5 cases were positive for c-myc and 18 negative or slightly positive. Survivin was not detected in non-cancerous adjacent liver tissues. The expression of survivin in HCC had no association with tumor size, capsule status, the classification of cirrhosis and TNM stage (P 〉 0.05), but with portal vein tumor thrombus and local recurrence (P 〈0.05). The expression of survivin was significantly correlated with the expression of c-myc in HCC (P 〈 0.05). Conclusion Survivin probably promotes the metastasis of HCC by enhancing the function of c-mvc, and survivin could be a new diagnostic/therapeutic target in HCC.
出处
《实用临床医药杂志》
CAS
2005年第9期75-78,共4页
Journal of Clinical Medicine in Practice
基金
江苏省医学135人才基金(135-43)